公开(公告)号：US20220133772A1

公开(公告)日：2022-05-05

申请号：US17525465

申请日：2021-11-12

申请人： PlantTec Medical GmbH

发明人： Joachim LAAS ,  Kai-Oliver MUTZ

IPC分类号： A61K31/718 ,  A61P17/02 ,  A61K31/194

摘要： A medication is disclosed, and the medication includes carboxymethylated starch. The medication includes a citrate and/or citric acid for reducing postoperative adhesions. The citrate and/or citric acid is/are situated on the surface of granules of the starch, and includes 1 to 20 percent by weight of citrate and/or citric acid relative to the starch. A method of treating postoperative adhesions by administering the topical medication for reducing postoperative adhesions to a postoperative adhesion of a subject, and a use of the topical medication.

公开(公告)号：US11318159B2

公开(公告)日：2022-05-03

申请号：US16825628

申请日：2020-03-20

申请人： Uplifting Results Labs, Inc.

发明人： Marc Washington ,  Ren-Hau Lai ,  Mengyu Zhao

IPC分类号： A61K31/718 ,  A23L33/22 ,  A23L33/115 ,  A23L33/185 ,  A61K9/00 ,  A61K38/00

摘要： A health benefiting daily nutrition includes protein, the protein having a protein weight. The health benefiting daily nutrition includes fiber, the fiber having a fiber weight. The fiber weight is more than 5 g. A ratio of [the protein weight]:[the fiber weight]=1:0.5-1.5.

公开(公告)号：US11123321B2

公开(公告)日：2021-09-21

申请号：US17132652

申请日：2020-12-23

申请人： VIFOR (INTERNATIONAL) AG

发明人： Peter Geisser ,  Erik Philipp ,  Walter Richie

IPC分类号： A61K31/295 ,  A61P7/06 ,  A61K31/718 ,  A61K33/26 ,  A61K47/61 ,  A61K45/06 ,  C08B31/18 ,  C08B30/18 ,  C08B37/00

摘要： A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron(III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, a process for its production and a medicament for the treatment and prophylaxis of iron deficiency conditions.

公开(公告)号：US20210186056A1

公开(公告)日：2021-06-24

申请号：US16769465

申请日：2017-12-05

申请人： Hill's Pet Nutrition, Inc.

发明人： Matthew JACKSON ,  Christopher WALDY ,  Dennis JEWELL ,  Eden EPHRAIM

IPC分类号： A23K20/163 ,  A23K10/30 ,  A23K50/40 ,  A23K40/25 ,  A61K31/718 ,  A61K9/00

摘要： Disclosed herein is a pet food composition and methods of making a pet food composition using an extrusion process, wherein the resultant pet food composition comprises an enhanced level of resistant starch. The pet food compositions disclosed herein may increase the proportions of beneficial gastrointestinal bacteria, such as Lactobacillus and Bifidobacterium, while decreasing deleterious bacteria such as Megamonas. The improved microbial environment resulting from the pet food compositions disclosed herein having an enhanced level of resistant starch may lead to both improved gastrointestinal and psychobiotic health for the animal consuming the pet food composition.

公开(公告)号：US11026384B2

公开(公告)日：2021-06-08

申请号：US16217729

申请日：2018-12-12

申请人： Zhongyi Li ,  Matthew Kennedy Morell

发明人： Zhongyi Li ,  Matthew Kennedy Morell

IPC分类号： A61K31/718 ,  A01H5/10 ,  C12N15/82 ,  C12Q1/25

摘要： The invention provides barley grain comprising a reduced level or activity of starch synthase IIa protein and a starch content of at least 41% (w/w) and methods of producing, identifying and using same. The grain may comprise an amylase content of at least 50%, a β-glucan content of 5-9% (w/w) or greater than 9% (w/w), and/or a fructan content of 3-11% (w/w). The fructan may comprise a degree of polymerization from about 3 to about 12. For example, the plant and grain comprises a sex6-292 allele and/or an amo1 mutation. A food or beverage product, and methods of producing a food or beverage product, comprising obtaining or producing the subject grain and processing the grain to produce the product. Also contemplated are methods of improving one or more indicators of health in a mammal comprising administering a composition comprising the subject barley grain or a product comprising same.

公开(公告)号：US10980823B2

公开(公告)日：2021-04-20

申请号：US16531349

申请日：2019-08-05

申请人： Mars, Incorporated

发明人： Alexandre Feugier ,  Delphine Clero

IPC分类号： A61K31/7004 ,  A61K31/718 ,  A61K38/01 ,  A23K20/163 ,  A23K50/42 ,  A23K50/48 ,  A23K10/26 ,  A23J1/10 ,  A61K35/57 ,  A23K1/10 ,  A23K1/16 ,  A23K1/18

摘要： The present invention relates to a foodstuff comprising feather hydrolysate for use in improving performance during exercise and/or improving recovery after exercise in a dog. It also relates to a method of improving the performance in a dog during exercise and/or improving recovery after exercise, the method comprising administering to a dog a foodstuff which comprises feather hydrolysate.

公开(公告)号：US20210100830A1

公开(公告)日：2021-04-08

申请号：US17125618

申请日：2020-12-17

申请人： QINGDAO CHENLAND MARINE BIOTECHNOLOGY CO., LTD.

发明人： Baoqun WANG ,  Shasha LIN ,  Shengcan ZOU

IPC分类号： A61K31/718 ,  C08B30/12 ,  A61K9/14 ,  A61P31/04 ,  A61P17/02

摘要： Disclosed is a preparation method of a starch-based hemostatic powder, comprising the following steps: (1) starch modification; (2) emulsification and crosslinking; (3) separation, purification, drying and sterilization. Provided is a starch-based hemostatic powder, which has a simple preparation process and a controllable cost. After being modified, raw material medical potato starch has a high degree of emulsification and crosslinking and a good and uniform spherical shape, and has a porous structure. Moreover, the product has good biocompatibility, low biological cytotoxicity, and obvious antibacterial effect; the product has a high liquid absorption ratio, and quickly forms a gel to cover the wound surface after liquid absorption, thus achieving a good hemostatic effect. The starch-based hemostatic powder is an excellent biomedical product, and can be used for clinical wound treatment, surgery to prevent organ adhesion, and bleeding from various wounds.

公开(公告)号：US20210054105A1

公开(公告)日：2021-02-25

申请号：US17087132

申请日：2020-11-02

申请人： VIFOR (INTERNATIONAL) AG

发明人： Peter Geisser ,  Erik Philipp ,  Walter Richle

IPC分类号： C08B30/18 ,  A61P7/06 ,  A61K31/295 ,  A61K31/718 ,  A61K33/26 ,  A61K45/06 ,  C08B31/18 ,  A61K47/61 ,  C08B37/00

摘要： A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron(III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, a process for its production and a medicament for the treatment and prophylaxis of iron deficiency conditions.

公开(公告)号：US20210001031A1

公开(公告)日：2021-01-07

申请号：US17024039

申请日：2020-09-17

申请人： Medtronic, Inc.

发明人： Martin T. GERBER ,  Christopher M. HOBOT

IPC分类号： A61M1/28 ,  A61K31/7004 ,  A61K31/718

摘要： The invention relates to systems and methods for making intracycle adjustments to an osmotic agent concentration of peritoneal dialysate inside the peritoneal cavity of a patient. The systems and methods include osmotic agent sources, flow paths, and processors to adjust the osmotic agent concentration of dialysate in the peritoneal cavity of the patient. The method can include infusing peritoneal dialysate containing an osmotic agent into the peritoneal cavity of a patient; monitoring one or more patient parameters; and adjusting the osmotic agent concentration of the peritoneal dialysate in the peritoneal cavity of the patient by infusing a concentrated osmotic agent solution or by infusing sterile fluid into the peritoneal cavity of the patient using an on-line peritoneal dialysis machine. The system can include a peritoneal dialysis cycler.

公开(公告)号：US20200297848A1

公开(公告)日：2020-09-24

申请号：US16894505

申请日：2020-06-05

申请人： Chelation Partners Incorporated

发明人： Bruce Edward HOLBEIN ,  Minhua FENG ,  Ann Louise HUBER ,  Denis Keith KIDBY

IPC分类号： A61K47/02 ,  A01N43/40 ,  A61K31/721 ,  A61K31/718 ,  A61K31/745 ,  A61K31/79 ,  A61K31/785 ,  C02F1/68 ,  A61K47/61 ,  A61K47/58 ,  A01N25/10 ,  A61K31/351 ,  A61K31/4196 ,  A61K31/43 ,  A61K31/4412 ,  A61K31/496 ,  A61K31/513 ,  A61K31/565 ,  A61K31/65 ,  A61K31/7036 ,  A61K31/7048

摘要： The present invention provides for metal chelating compositions which are soluble in aqueous media. The present invention also provides chelating compositions that possess acceptable iron sequestering strengths and are able to present a physical form that potentially inhibits (e.g. does not permit easy) access of iron sequestered by the compositions to the cells being targeted. Compositions comprising chelating aspects affixed to or incorporated into suitable carrier materials such that the resulting metal chelating composition is soluble in aqueous media are also provided. Disclosed herein are chelating compositions, for chelating one or more essential metals. The chelating compositions being soluble in an aqueous medium and comprising one or more metal binding chemical groups affixed to or incorporated into the structure of a carrier material, such that the resulting chelating composition is able to bind one or more metals, and remains substantially soluble in the aqueous medium with its bound metal or metals.